Disposition of 07 shares by Graf Finckenstein Friedrich of Iovance Biotherapeutics subject to Rule 16b-3
| IOVA Stock | USD 5.57 0.23 4.31% |
About 55% of Iovance Biotherapeutics' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Iovance Biotherapeutics suggests that some traders are interested. The current market sentiment, together with Iovance Biotherapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Iovance Biotherapeutics stock news signals to limit their universe of possible portfolio assets.
Iovance |
Filed transaction by Iovance Biotherapeutics Officer Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Iovance Biotherapeutics Fundamental Analysis
We analyze Iovance Biotherapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Iovance Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Iovance Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Iovance Biotherapeutics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Iovance Biotherapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iovance Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Iovance Biotherapeutics could also be used in its relative valuation, which is a method of valuing Iovance Biotherapeutics by comparing valuation metrics with similar companies.
Peers
Iovance Biotherapeutics Related Equities
| PTCT | PTC Therapeutics | 4.33 | ||||
| APLS | Apellis Pharmaceuticals | 0.22 | ||||
| CVAC | CureVac NV | 0.54 | ||||
| SRPT | Sarepta Therapeutics | 1.38 | ||||
| KRYS | Krystal Biotech | 1.61 | ||||
| MDGL | Madrigal Pharmaceuticals | 4.13 | ||||
| HEPA | Hepion Pharmaceuticals | 10.00 | ||||
| OCEA | Ocean Biomedical | 13.33 |
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |